Literature DB >> 2589430

Perinatal outcome in very preterm births with twin-twin transfusion syndrome.

D M Shah1, D Chaffin.   

Abstract

We retrospectively studied 48 pairs of twin gestations delivered between 24 and 28 weeks' gestation from 1975 to 1986 at Vanderbilt University Medical Center. The incidence of fetofetal transfusion syndrome was 20%, more than double the incidence previously reported in large series of twin deliveries that encompassed a wider gestational age range. The overall mortality was 55%, and mortality for the fetofetal transfusion group was 70%, whereas a subset of the fetofetal transfusion group, those without weight discordancy, had a mortality rate of 75%. Our findings suggest that traditional reliance on ultrasonographic criteria for diagnosis of fetofetal transfusion will not detect 40% of such cases. The poor outcome data suggest a need for innovative approaches to diagnosis and treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2589430     DOI: 10.1016/0002-9378(89)90644-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  The amniotic fluid transcriptome as a guide to understanding fetal disease.

Authors:  Lillian M Zwemer; Diana W Bianchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-13       Impact factor: 6.915

2.  Two cases of dizygotic triplet pregnancy following conventional in vitro fertilization.

Authors:  Kazunori Furugori; Hisao Ando; Tomomi Ito; Shigehiko Mizutani
Journal:  Reprod Med Biol       Date:  2003-03-25

3.  Twin-twin transfusion syndrome: a five year review.

Authors:  Y C Seng; V S Rajadurai
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-11       Impact factor: 5.747

4.  Global gene expression analysis of amniotic fluid cell-free RNA from recipient twins with twin-twin transfusion syndrome.

Authors:  Lisa Hui; Heather C Wick; Kenneth J Moise; Anthony Johnson; Francois Luks; Sina Haeri; Kirby L Johnson; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2013-06-04       Impact factor: 3.050

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.